Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Henry

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|December 4, 2009
High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infectionJason Baker, Woubeshet Ayenew, Harrison Quick, et al.
Antiviral Therapy|February 4, 2012
Effect of abacavir on acute changes in biomarkers associated with cardiovascular dysfunctionPragna Patel, Tim Bush, Turner Overton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2009
Untreated HIV infection and large and small artery elasticityJason V Baker, Daniel Duprez, Joshua Rapkin, et al.
Neurochemistry International|November 26, 2013
Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridgeJon D Gaffaney, Madhur Shetty, Bruce Felts, et al.
Neurochemistry International|August 21, 2018
Identification of the benztropine analog [<sup>125</sup>I]GA II 34 binding site on the human dopamine transporterMichael J Tomlinson, Danielle Krout, Akula Bala Pramod, et al.
Lancet (London, England)|February 22, 2005
Blockade of HERG channels by HIV protease inhibitorsBlake D Anson, Joel G R Weaver, Michael J Ackerman, et al.
AIDS (London, England)|March 2, 2002
Concentration-controlled compared with conventional antiretroviral therapy for HIV infectionCourtney V Fletcher, Peter L Anderson, Thomas N Kakuda, et al.
Sexually Transmitted Diseases|January 18, 2012
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United StatesPragna Patel, Tim Bush, Kenneth H Mayer, et al.
The Journal of Infectious Diseases|July 23, 2018
The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined AnalysisÁlvaro H Borges, Jacqueline Neuhaus, Shweta Sharma, et al.
AIDS (London, England)|May 16, 2007
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adultsJudith S Currier, Michelle A Kendall, W Keith Henry, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|December 4, 2009
High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infectionJason Baker, Woubeshet Ayenew, Harrison Quick, et al.
Antiviral Therapy|February 4, 2012
Effect of abacavir on acute changes in biomarkers associated with cardiovascular dysfunctionPragna Patel, Tim Bush, Turner Overton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2009
Untreated HIV infection and large and small artery elasticityJason V Baker, Daniel Duprez, Joshua Rapkin, et al.
Neurochemistry International|November 26, 2013
Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridgeJon D Gaffaney, Madhur Shetty, Bruce Felts, et al.
Neurochemistry International|August 21, 2018
Identification of the benztropine analog [<sup>125</sup>I]GA II 34 binding site on the human dopamine transporterMichael J Tomlinson, Danielle Krout, Akula Bala Pramod, et al.
Lancet (London, England)|February 22, 2005
Blockade of HERG channels by HIV protease inhibitorsBlake D Anson, Joel G R Weaver, Michael J Ackerman, et al.
AIDS (London, England)|March 2, 2002
Concentration-controlled compared with conventional antiretroviral therapy for HIV infectionCourtney V Fletcher, Peter L Anderson, Thomas N Kakuda, et al.
Sexually Transmitted Diseases|January 18, 2012
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United StatesPragna Patel, Tim Bush, Kenneth H Mayer, et al.
The Journal of Infectious Diseases|July 23, 2018
The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined AnalysisÁlvaro H Borges, Jacqueline Neuhaus, Shweta Sharma, et al.
AIDS (London, England)|May 16, 2007
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adultsJudith S Currier, Michelle A Kendall, W Keith Henry, et al.
Pageof 14